Beech Hill Advisors Inc. Has $1.84 Million Position in Kenvue Inc. $KVUE

Key Points

• Beech Hill Advisors Inc. reduced its stake in Kenvue Inc. by 19.0%, now holding 87,686 shares worth approximately $1.84 million.
• Institutional investors own 97.64% of Kenvue's stock, with notable increases in holdings by Vanguard Group and Voya Investment Management.
• Kenvue's stock analysts have mixed ratings, with a consensus rating of "Hold" and an average target price of $21.18, following recent price adjustments by various firms.

Beech Hill Advisors Inc. cut its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 19.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 87,686 shares of the company's stock after selling 20,554 shares during the quarter. Beech Hill Advisors Inc.'s holdings in Kenvue were worth $1,835,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in shares of Kenvue by 4.9% during the 1st quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company's stock valued at $5,494,882,000 after buying an additional 10,600,682 shares during the last quarter. Third Point LLC acquired a new stake in Kenvue in the first quarter valued at approximately $213,422,000. Maverick Capital Ltd. bought a new stake in Kenvue in the first quarter worth approximately $203,036,000. Nuveen LLC acquired a new position in shares of Kenvue during the 1st quarter worth $187,123,000. Finally, Voya Investment Management LLC raised its holdings in shares of Kenvue by 131.3% during the 1st quarter. Voya Investment Management LLC now owns 12,131,468 shares of the company's stock valued at $290,557,000 after purchasing an additional 6,886,784 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Analyst Ratings Changes

KVUE has been the subject of a number of recent research reports. The Goldman Sachs Group decreased their price objective on shares of Kenvue from $22.00 to $19.00 and set a "neutral" rating for the company in a report on Thursday, October 2nd. Rothschild Redb upgraded Kenvue from a "hold" rating to a "strong-buy" rating in a research note on Friday, September 26th. Bank of America lowered their price objective on Kenvue from $25.00 to $21.00 and set a "buy" rating on the stock in a report on Wednesday, October 8th. Canaccord Genuity Group reduced their target price on Kenvue from $29.00 to $26.00 and set a "buy" rating for the company in a report on Friday, August 8th. Finally, Rothschild & Co Redburn upgraded Kenvue from a "neutral" rating to a "buy" rating and lowered their price target for the company from $22.50 to $22.00 in a report on Friday, September 26th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $21.18.

Kenvue Trading Down 2.2%

Shares of Kenvue stock opened at $14.96 on Tuesday. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The company has a market cap of $28.71 billion, a price-to-earnings ratio of 20.22, a PEG ratio of 2.20 and a beta of 0.72. The company's fifty day simple moving average is $18.42 and its 200-day simple moving average is $20.97. Kenvue Inc. has a 1 year low of $14.05 and a 1 year high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping analysts' consensus estimates of $0.28 by $0.01. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The business had revenue of $3.84 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same period last year, the business earned $0.32 earnings per share. The firm's revenue for the quarter was down 4.0% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, sell-side analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were issued a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 5.5%. The ex-dividend date of this dividend was Wednesday, August 13th. This is a positive change from Kenvue's previous quarterly dividend of $0.21. Kenvue's payout ratio is currently 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.